
TPA-Induced Dermatitis Model
TPA (12-O-tetradecanoylphorbol-13-acetate) applied topically to a mouse ear causes a strong local inflammatory response. It activates protein kinase C (PKC), driving inflammatory mediators and leukocyte recruitment, increased vascular permeability, and ultimately ear edema/swelling and erythema.


Vehicle/vehicle, TPA 0.1%/vehicle, TPA 0.1%/clobetasol, TPA 0.1%/indomethacin and TPA 0.1%/crisaborole groups.